Proposed Rulemaking
The Board of Pharmacy is proposing revisions to state rules as outlined below.
The public comment period is now closed.
Session Law:
The statutory authority to adopt these rules under the expedited rulemaking process is Minnesota Laws 2024, Regular Session, Chapter 127, Article 60, Subd. 25.
- Sec. 25. RULEMAKING; BOARD OF PHARMACY. The Board of Pharmacy must amend Minnesota Rules, part 6800.3400, to permit and promote the inclusion of the following on a prescription label: (1) the complete and unabbreviated generic name of the drug; and (2) instructions written in plain language explaining the patient-specific indications for the drug if the patient-specific indications are indicated on the prescription. The Board of Pharmacy must comply with Minnesota Statutes, section 14.389, in adopting the amendment to the rule.
Current rule:
Minnesota Rule 6800.3400
Subject matter:
Amendment to Rules Governing Prescription Bottle Labeling
Summary of proposed changes:
Drugs dispensed to or for a patient, other than an inpatient of a hospital, may contain unabbreviated names of generic drugs, instructions in plain language explaining patient-specific indications for the drug if the patient-specific indications are indicated on the prescription.
Documents
Information about eComments is available on the Court of Administrative Hearings website.If you have additional questions please contact the Board at pharmacy.board@state.mn.us using the subject Rulemaking.
Click this link to sign up for email updates from the Board of Pharmacy.